Briska Jifrina Premnath

Briska Jifrina Premnath

Auto-generated profile, based on publicly available information

Briska Jifrina Premnath

Department of Biochemistry and Biotechnology Faculty of Science, Annamalai University Chidambaram Tamil Nadu India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2024 in Journal of King Saud University – Science
Verified
Journal Article
Open access
MKManoj Kumar
Manoj Kumar
BPBriska Jifrina Premnath
Briska Jifrina Premnath
RPRamya Parimelazhagan
Ramya Parimelazhagan
CGChandramohan Govindasamy
Chandramohan Govindasamy
KSKamala-Kannan Seralathan
Kamala-Kannan Seralathan
NNNalini Namatchivayam
Nalini Namatchivayam
Objectives: The current research explores the anticancer effects of pH sensitive CVC-ZnO QDs (Carvacrol-loaded Zinc Oxide Quantum Dots) on DMBA induced mammary carcinoma in rats. Methods: Female SD rats were used, and mammary cancer was induced by chemical carcinogen via subcutaneous injection near the mammary gland. Different concentrations of CVC-ZnO QDs were orally supplemented to evaluate the optimum dose. We assessed the growth rate, body weight changes, tumor volume, tumor incidence and tumor burden in both the inducer and treatment groups. We also evaluated the biochemical parameters (antioxidant status, lipid peroxidation, detoxification enzymes, and lipid profile) and histopathological changes in the kidney and mammary tissues. Results: Our findings indicate that CVC-ZnO QDs treated rats significantly decreased the tumor weight, incidence, burden, lipid peroxidation levels, phase I detoxification enzyme activities and increased the body weight, phase II detoxification enzyme activities, and antioxidant status compared to the DMBA alone treated rats. CVC-ZnO QDs treatment also altered the lipid profile of plasma and mammary tissue. Furthermore, histopathological results confirmed that the CVC-ZnO QDs protect against DMBA-mediated damage to the mammary and kidney. Conclusion: The findings indicate that the CVC-ZnO QDs administered at 4 mg/kg b.w exhibited a significant anticancer effect against DMBA-induced mammary cancer.

2 May 2025 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
MKManoj Kumar
Manoj Kumar
BPBriska Jifrina Premnath
Briska Jifrina Premnath
NNNalini Namasivayam
Nalini Namasivayam

30 March 2024 in Biosciences Biotechnology Research Asia
Verified
Journal Article
Open access
BPBriska Jifrina Premnath
Briska Jifrina Premnath
MKManoj Kumar
Manoj Kumar
NNNalini Namatchivayam
Nalini Namatchivayam
Biosciences, Biotechnology Research Asia is an international, open access, peer reviewed research journal covering all aspects of Biosciences and Biotechnology field.